Lv3
208 积分 2024-07-11 加入
Cardiovascular–kidney–metabolic syndrome and MASLD: integrating medical perspectives
1天前
待确认
A Simple Protocol for the Isolation and Culture of Hepatocytes from MASLD Mice
3个月前
已关闭
Sarcopenia and MASLD: novel insights and the future
5个月前
已完结
Dual blockade of endothelin A and angiotensin II type 1 receptors with sparsentan as a novel treatment strategy to alleviate IgA nephropathy
6个月前
已完结
Pathophysiology and therapeutic options for cirrhotic portal hypertension
6个月前
已完结
Renal Complications in Portal Hypertension
6个月前
已关闭
Interaction of inflammation and portal hypertension in cirrhosis progression
6个月前
已完结
Vascular mechanotransduction
8个月前
已完结
Molecular Mechanisms of Increased Intrahepatic Resistance in Portal Hypertension
8个月前
已关闭
Endothelin receptor antagonists in chronic kidney disease
8个月前
已完结
皖公网安备34019202002308
